Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald P Levine

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Infectious Disease Clinics of North America|October 10, 2002
Infective endocarditis in the injection drug userPatricia D Brown, Donald P Levine
American Health & Drug Benefits|August 16, 2014
Methicillin-Resistant Staphylococcus aureus: A Growing Risk in the Hospital and in the CommunityJose L Raygada, Donald P Levine
The American Journal of the Medical Sciences|February 25, 2019
Impact of Delayed Therapy in Serious Bacterial Infections: Role of Technology and the Clinician at the BedsideMiriam T Levine, Donald P Levine
Journal of Critical Care|November 13, 2009
Outcome of patients with injection drug use-associated endocarditis admitted to an intensive care unitGhulam Saydain, Jatinder Singh, Bhavinkumar Dalal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2011
Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targetsRavina Kullar, Susan L Davis, Donald P Levine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2004
Clinafloxacin for the treatment of bacterial endocarditisDonald P Levine, H Preston Holley, Irene Eiseman, et al.
Expert Opinion on Pharmacotherapy|May 19, 2012
Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infectionAnthony M Casapao, Molly E Steed, Donald P Levine, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2007
Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureusThomas P Lodise, Peggy S McKinnon, Donald P Levine, et al.
Expert Review of Anti-Infective Therapy|July 14, 2015
Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profileKarl Evans R Henson, Miriam T Levine, Eunice Ann H Wong, et al.
Pharmacotherapy|January 12, 2013
Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremiaRavina Kullar, Susan L Davis, Keith S Kaye, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Infectious Disease Clinics of North America|October 10, 2002
Infective endocarditis in the injection drug userPatricia D Brown, Donald P Levine
American Health & Drug Benefits|August 16, 2014
Methicillin-Resistant Staphylococcus aureus: A Growing Risk in the Hospital and in the CommunityJose L Raygada, Donald P Levine
The American Journal of the Medical Sciences|February 25, 2019
Impact of Delayed Therapy in Serious Bacterial Infections: Role of Technology and the Clinician at the BedsideMiriam T Levine, Donald P Levine
Journal of Critical Care|November 13, 2009
Outcome of patients with injection drug use-associated endocarditis admitted to an intensive care unitGhulam Saydain, Jatinder Singh, Bhavinkumar Dalal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2011
Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targetsRavina Kullar, Susan L Davis, Donald P Levine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2004
Clinafloxacin for the treatment of bacterial endocarditisDonald P Levine, H Preston Holley, Irene Eiseman, et al.
Expert Opinion on Pharmacotherapy|May 19, 2012
Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infectionAnthony M Casapao, Molly E Steed, Donald P Levine, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2007
Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureusThomas P Lodise, Peggy S McKinnon, Donald P Levine, et al.
Expert Review of Anti-Infective Therapy|July 14, 2015
Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profileKarl Evans R Henson, Miriam T Levine, Eunice Ann H Wong, et al.
Pharmacotherapy|January 12, 2013
Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremiaRavina Kullar, Susan L Davis, Keith S Kaye, et al.
Pageof 5